Skip to main content
. 2018 Jul 13;7(7):175. doi: 10.3390/jcm7070175

Figure 3.

Figure 3

TWEAK serum concentrations do not predict survival in patients with pancreatic cancer. (A) Serum TWEAK concentrations were measured in patients that succumbed to death and survivors; (B) ROC curve analyses determining the prognostic value of TWEAK in patients with pancreatic cancer; (C) Kaplan-Meier curve analysis with respect to patients’ serum TWEAK concentrations (cut-off determined by using the median); (D) Kaplan-Meier curve analysis with respect to patients’ serum TWEAK concentrations (ideal cut-off value).